Integral Health Asset Management as of Dec. 31, 2020
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 57 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 5.0 | $17M | 195k | 86.51 | |
| Acadia Healthcare (ACHC) | 4.7 | $16M | 315k | 50.26 | |
| Arena Pharmaceuticals Com New | 4.6 | $15M | 200k | 76.83 | |
| Nevro (NVRO) | 4.5 | $15M | 88k | 173.10 | |
| LHC | 4.3 | $15M | 68k | 213.32 | |
| Charles River Laboratories (CRL) | 3.9 | $13M | 53k | 249.87 | |
| Chemocentryx | 3.3 | $11M | 180k | 61.92 | |
| Cytokinetics Com New (CYTK) | 3.2 | $11M | 525k | 20.78 | |
| Envista Hldgs Corp (NVST) | 3.2 | $11M | 320k | 33.73 | |
| McKesson Corporation (MCK) | 2.8 | $9.6M | 55k | 173.93 | |
| Blueprint Medicines (BPMC) | 2.8 | $9.5M | 85k | 112.15 | |
| PerkinElmer (RVTY) | 2.8 | $9.3M | 65k | 143.51 | |
| Anthem (ELV) | 2.7 | $9.0M | 28k | 321.11 | |
| Abbott Laboratories (ABT) | 2.6 | $8.8M | 80k | 109.49 | |
| Eli Lilly & Co. (LLY) | 2.5 | $8.4M | 50k | 168.84 | |
| Gw Pharmaceuticals Ads | 2.5 | $8.4M | 73k | 115.41 | |
| Mirati Therapeutics | 2.4 | $8.1M | 37k | 219.65 | |
| Becton, Dickinson and (BDX) | 2.4 | $8.0M | 32k | 250.22 | |
| Abbvie (ABBV) | 2.2 | $7.5M | 70k | 107.16 | |
| BioMarin Pharmaceutical (BMRN) | 2.2 | $7.5M | 85k | 87.69 | |
| AmerisourceBergen (COR) | 2.0 | $6.8M | 70k | 97.76 | |
| CVS Caremark Corporation (CVS) | 2.0 | $6.8M | 100k | 68.30 | |
| Reata Pharmaceuticals Cl A | 1.8 | $6.2M | 50k | 123.62 | |
| Encompass Health Corp (EHC) | 1.7 | $5.8M | 70k | 82.69 | |
| Avantor (AVTR) | 1.7 | $5.6M | 200k | 28.15 | |
| Johnson & Johnson (JNJ) | 1.6 | $5.5M | 35k | 157.37 | |
| Denali Therapeutics (DNLI) | 1.4 | $4.8M | 58k | 83.76 | |
| Guardant Health (GH) | 1.3 | $4.5M | 35k | 128.89 | |
| Natera (NTRA) | 1.3 | $4.5M | 45k | 99.51 | |
| Medtronic SHS (MDT) | 1.2 | $4.1M | 35k | 117.14 | |
| Zai Lab Adr (ZLAB) | 1.2 | $4.1M | 30k | 135.33 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.1 | $3.8M | 50k | 76.74 | |
| Shockwave Med | 1.1 | $3.6M | 35k | 103.71 | |
| Pennant Group (PNTG) | 1.0 | $3.5M | 60k | 58.07 | |
| Hca Holdings (HCA) | 1.0 | $3.3M | 20k | 164.45 | |
| Intellia Therapeutics (NTLA) | 1.0 | $3.3M | 60k | 54.40 | |
| Globus Med Cl A (GMED) | 1.0 | $3.3M | 50k | 65.22 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $3.2M | 75k | 43.33 | |
| Kura Oncology (KURA) | 0.9 | $3.1M | 95k | 32.66 | |
| Aerie Pharmaceuticals | 0.8 | $2.7M | 200k | 13.51 | |
| Alector (ALEC) | 0.7 | $2.5M | 165k | 15.13 | |
| Biogen Idec (BIIB) | 0.7 | $2.4M | 10k | 244.90 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.7 | $2.4M | 135k | 17.67 | |
| Akero Therapeutics (AKRO) | 0.7 | $2.2M | 85k | 25.80 | |
| Macrogenics (MGNX) | 0.6 | $2.1M | 90k | 22.86 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $2.0M | 15k | 130.00 | |
| Ptc Therapeutics I (PTCT) | 0.5 | $1.8M | 30k | 61.03 | |
| Replimune Group (REPL) | 0.5 | $1.8M | 48k | 38.15 | |
| eHealth (EHTH) | 0.5 | $1.8M | 25k | 70.60 | |
| Progyny (PGNY) | 0.5 | $1.7M | 40k | 42.40 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $1.7M | 50k | 33.30 | |
| Karyopharm Therapeutics (KPTI) | 0.5 | $1.5M | 100k | 15.48 | |
| Myovant Sciences | 0.4 | $1.4M | 50k | 27.62 | |
| Biohaven Pharmaceutical Holding | 0.4 | $1.3M | 15k | 85.73 | |
| Precision Biosciences Ord | 0.3 | $1.2M | 140k | 8.34 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.3 | $1.0M | 300k | 3.42 | |
| Intra Cellular Therapies (ITCI) | 0.3 | $954k | 30k | 31.80 |
